首页> 外文期刊>Journal of Molecular Endocrinology >Appearance of the pituitary factor Pit-1 increases chromatin remodeling at hypersensitive site III in the human GH locus
【24h】

Appearance of the pituitary factor Pit-1 increases chromatin remodeling at hypersensitive site III in the human GH locus

机译:垂体因子Pit-1的出现增加了人GH基因位点超敏部位III的染色质重塑

获取原文
           

摘要

Expression of pituitary and placental members of the human GH and chorionic somatomammotropin (CS) gene family is directed by an upstream remote locus control region (LCR). Pituitary-specific expression of GH requires direct binding of Pit-1 (listed as POU1F1 in the HUGO database) to sequences marked by a hypersensitive site (HS) region (HS I/II) 14.6?kb upstream of the GH-N gene (listed as GH1 in the HUGO database). We used human embryonic kidney 293 (HEK293) cells overexpressing wild-type and mutant Pit-1 proteins as a model system to gain insight into the mechanism by which Pit-1 gains access to the GH LCR. Addition of Pit-1 to these cells increased DNA accessibility at HS III, located 28?kb upstream of the human GH-N gene, in a POU homeodomain-dependent manner, as reflected by effects on histone hyperacetylation and RNA polymerase II activity. Direct binding of Pit-1 to HS III sequences is not supported. However, the potential for binding of ETS family members to this region has been demonstrated, and Pit-1 association with this ETS element in HS III sequences requires the POU homeodomain. Also, both ETS1 and ELK1 co-precipitate from human pituitary extracts using two independent sources of Pit-1 antibodies. Finally, overexpression of ELK1 or Pit-1 expression in HEK293 cells increased GH-N RNA levels. However, while ELK1 overexpression also stimulated placental CS RNA levels, the effect of Pit-1 appeared to correlate with ETS factor levels and target GH-N preferentially. These data are consistent with recruitment and an early role for Pit-1 in remodeling of the GH LCR at the constitutively open HS III through protein–protein interaction.
机译:人GH和绒毛膜生长激素(CS)基因家族的垂体和胎盘成员的表达是由上游远程基因座控制区(LCR)指导的。 GH的垂体特异性表达需要将Pit-1(在HUGO数据库中列为POU1F1)直接与GH-N基因上游14.6?kb的超敏位(HS)区(HS I / II)标记的序列结合(在HUGO数据库中列为GH1)。我们使用过表达野生型和突变型Pit-1蛋白的人胚肾293(HEK293)细胞作为模型系统,以深入了解Pit-1获取GH LCR的机制。将Pit-1添加到这些细胞中,可以以POU同源域依赖的方式提高人GH-N基因上游28kb处HS III的DNA可及性,这反映在对组蛋白超乙酰化和RNA聚合酶II活性的影响上。不支持Pit-1与HS III序列的直接结合。然而,已经证明了ETS家族成员与该区域结合的潜力,并且与HS III序列中该ETS元件的Pit-1结合需要POU同源域。同样,ETS1和ELK1都使用两种独立来源的Pit-1抗体从人垂体提取物中共沉淀。最后,HEK293细胞中ELK1或Pit-1表达的过表达增加了GH-N RNA的水平。然而,尽管ELK1过表达也刺激了胎盘CS RNA水平,但Pit-1的作用似乎与ETS因子水平相关,并优先靶向GH-N。这些数据与Pit-1的募集以及通过蛋白-蛋白相互作用在组成性开放的HS III上GH LCR重塑中的早期作用相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号